what to expect when starting retatrutide Understanding the dose Retatrutide Peptide Dosage – Why
Description
Semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1)
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
About Sodium and Health
The direct effect of GLP-1 on adipose tissue has been demonstrated in many studies
If you are in the middle of a flare, you will likely need to wait until it resolves
